1-2 of 2
Chandra Belani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial (CASSINI)

Alok A. Khorana, Gerald A. Soff, Ajay K. Kakkar, Saroj Vadhan-Raj, Hanno Riess, Ted Wun, Michael B. Streiff, David A. Garcia, Howard A. Liebman, Chandra Belani, Eileen M. O'Reilly, Jai N Patel, Habte A. Yimer, Peter Wildgoose, Paul Burton, Ujjwala Vijapurkar, Simrati Kaul, John Eikelboom, Robert D. McBane, Kenneth A. Bauer, MD, Nicole M. Kuderer, Gary H. Lyman
Journal: Blood
Blood (2018) 132 (Supplement 1): LBA-1.
https://doi.org/10.1182/blood-2018-120738
Published: 2018
Journal Articles

Combination of the Proteasome Inhibitor Bortezomib and a Histone Deacetylase Inhibitor PXD101 Results in Synergistic Inhibition of Osteoclastogenesis and Significantly Stronger Inhibition of Multiple Myeloma Growth In Vitro and In Vivo .

Rentian Feng, PhD, Ana B. Oton, MD, Kenneth Patrene, Gulsum Anderson, PhD, Markus Y. Mapara, MD, PhD, Chandra Belani, MD, David Roodman, MD, PhD, Suzanne Lentzsch, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 507.
https://doi.org/10.1182/blood.V108.11.507.507
Published: 2006